Ekso Bionics Holdings, Inc.

Adial Pharmaceuticals, Inc

Haoxi Health Technology Limited Class A

Psyence Biomedical Ltd. Common Shares

Inhibikase Therapeutics, Inc.

Palisade Bio, Inc.

Medical Properties Trust, Inc.

Cue Biopharma, Inc.

Standard BioTools Inc.

Dilution score: 22/100 (LOW), 24.0 months cash

Short interest: 8.07% of float, squeeze risk: MODERATE

Dilution score: 52/100 (HIGH), 3.1 months cash

SW convergence: 50/100 (Neutral), 1 bullish / 0 bearish signals

Short interest: 9.61% of float, squeeze risk: LOW

<article class="bts-verified-summary" data-ticker="EKSO">
<p>Ekso Bionics Holdings, Inc. Common Stock (EKSO) has no currently recruiting or active clinical trials where it is listed as lead sponsor on ClinicalTrials.gov.</p>
<p>EKSO has 2 Form 4 insider filings recorded at the SEC in the past 30 days<sup><a href="#fn-1">[1]</a></sup>.</p>
<section class="sources" data-nosnippet aria-label="Sources"><h3>Sources</h3><ol><li id="fn-1">SEC EDGAR · 0001549084 (2026-04-11) <a href="https://efts.sec.gov/LATEST/search-index?q=%22EKSO%22&amp;forms=4&amp;dateRange=custom&amp;startdt=2026-03-12&amp;enddt=2026-04-11" rel="nofollow noopener noreferrer">↗</a></li></ol></section>
</article>

Ekso Bionics Holdings, Inc. Common Stock

SEC EDGAR — 0001549084

Ekso Bionics Holdings, Inc. Common Stock (EKSO) — BioTechSigns Verified Summary

Ekso Bionics Holdings, Inc. Common Stock (EKSO) has no currently recruiting or active clinical trials where it is listed as lead sponsor on ClinicalTrials.gov.

EKSO has 2 Form 4 insider filings recorded at the SEC in the past 30 days[1].

Sources:
[1] SEC EDGAR, 0001549084. Source last updated 2026-04-11, retrieved 2026-04-11.
    https://efts.sec.gov/LATEST/search-index?q=%22EKSO%22&forms=4&dateRange=custom&startdt=2026-03-12&enddt=2026-04-11